The company's device, a blood spectrometer connected to a mobile application, allows users to conduct blood tests, assess organ function, and detect tissue damage and harmful substances. Patients can now perform self-diagnosis and easily share reports with their doctors. ARCHIMEJ TECHNOLOGY's disruptive technology, SPECTROSCOPY 2.0®, leverages patented optical innovations to achieve unprecedented properties in absorption spectrometers, including measurement sensitivity, miniaturization, and manufacturing cost advantages. This technology finds applications in various markets, such as In-Vitro Diagnostic and Point of Care, providing a competitive edge over traditional biochemical analysis methods.